Insulin of glargine U300 - a Basal Insulin in the next Generation

被引：0
|
作者：
Luger, A. [1 ]
机构：
[1] Med Univ Wien, Univ Klin Innere Med 3, Klin Abt Endokrinol & Stoffwechsel, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
来源：
AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | 2015年 / 8卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 68
页数：3
相关论文
共 50 条
  • [21] More physiological circulating insulin and modulation of hepatic glucose production with insulin Glargine U300 vs U100 in type 1 diabetes
    Porcellati, F.
    Lucidi, P.
    Andreoli, A. Marinelli
    Cioli, P.
    Candeloro, P.
    Bolli, G. B.
    Fanelli, C. G.
    [J]. DIABETOLOGIA, 2017, 60 : S307 - S308
  • [22] Continuation of evolution: Headliner glargine U300
    Soyaltin, Utku Erdem
    Simsir, Ilgin Yildirim
    Cetinkalp, Sevki
    [J]. MEDICAL HYPOTHESES, 2018, 119 : 24 - 25
  • [23] COST-EFFECTIVENESS OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U300 IN THE NETHERLANDS: EVIDENCE FROM A RANDOMISED CONTROLLED TRIAL (RCT)
    Evans, M.
    Moes, R. J.
    Pedersen, K. S.
    Gundgaard, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S583 - S583
  • [24] Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
    Lau, Ip Tim
    Lee, Ka Fai
    So, Wing Yee
    Tan, Kathryn
    Yeung, Vincent Tok Fai
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 273 - 284
  • [25] Effect of basal insulin therapy with glargine U300 versus basal-bolus insulin therary in hospitalized patients with type 2 diabetes. Real-world study from India
    Mitra, Asis
    Ray, Saswati
    Jayan, Sushma
    [J]. CLINICAL DIABETOLOGY, 2021, 10 (02): : 180 - 187
  • [26] Management of Type 2 Diabetes Mellitus in a Patient with COVID-19: The Window of Insulin Glargine U300
    Topaloglu, Ulas Serkan
    Eren, Esma
    Simsek, Yasin
    [J]. KLIMIK JOURNAL, 2021, 34 (02) : 144 - 146
  • [27] Effect of Telephone Coaching Support on Glycemic Control in Type 2 Diabetes Treated with Glargine U300 Insulin
    Bellido Guerrero, Diego, Sr.
    Bellido, Virginia
    Morales, Cristobal, Sr.
    Garcia, Jose, Sr.
    Munoz-Garach, Araceli
    Fernandez Morera, Juan Luis
    Gonzalez Aguilera, Beatriz
    Lopez De la Torre, Martin
    Fuentealba, Paulina
    [J]. DIABETES, 2019, 68
  • [28] U300, a novel long-acting insulin formulation
    Sutton, Gemma
    Minguet, Joan
    Ferrero, Carmen
    Bramlage, Peter
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (12) : 1849 - 1860
  • [29] Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements
    Pearson, Scott M.
    Trujillo, Jennifer M.
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 9 (04) : 113 - 121
  • [30] Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements
    Pearson, Scott
    Trujillo, Jennifer
    [J]. PHARMACOTHERAPY, 2017, 37 (12): : E167 - E167
12345